We are live on ! Find out more
DMKJ

David M. Knott Jr Portfolio holdings

AUM $189M
1-Year Est. Return 67.72%
This Fund
S&P 500
This Quarter Est. Return
-17.88%
1 Year Est. Return
+67.72%
3 Year Est. Return
+169.37%
5 Year Est. Return
10 Year Est. Return
AUM
$238M
AUM Growth
-$75.8M
Cap. Flow
-$35M
Cap. Flow %
-14.69%
Top 10 Hldgs %
53.15%
Holding
208
New
68
Increased
23
Reduced
13
Closed
20
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
CLMT icon
1
Calumet Specialty Products
CLMT
$4.2B
$44.9M 18.87%
4,325,000
-67,500
-2% -$897K
GOOG icon
2
Alphabet (Google) Class C
GOOG
$4.19T
$12.3M 5.15%
112,220
+220
+0.2% +$26K
FBRT
3
Franklin BSP Realty Trust
FBRT
$703M
$11.6M 4.86%
859,047
+261,775
+44% +$3.73M
APO icon
4
Apollo Global Management
APO
$79.7B
$10.9M 4.58%
225,000
-25,000
-10% -$1.36M
LGND icon
5
Ligand Pharmaceuticals
LGND
$5.59B
$10.3M 4.31%
184,345
DCGO icon
6
DocGo
DCGO
$39.3M
$10M 4.2%
1,400,000
FTAI icon
7
FTAI Aviation
FTAI
$20B
$8.22M 3.45%
497,675
-85,132
-15% -$1.51M
PFE icon
8
Pfizer
PFE
$159B
$7.52M 3.16%
143,500
MITAW
9
DELISTED
Coliseum Acquisition Corp. Warrant
MITAW
$5.69M 2.39%
495,000
AGAC.WS
10
DELISTED
African Gold Acquisition Corp Warrants
AGAC.WS
$5.18M 2.18%
450,750
VRTX icon
11
Vertex Pharmaceuticals
VRTX
$137B
$4.79M 2.01%
17,000
JNJ icon
12
Johnson & Johnson
JNJ
$646B
$4.4M 1.85%
24,800
MDWT
13
DELISTED
Midwest Holding Inc. Common Stock
MDWT
$4.25M 1.79%
353,937
+60,000
+20% +$722K
BHVN
14
DELISTED
Biohaven Pharmaceutical Holding Company Ltd.
BHVN
$3.65M 1.53%
25,051
+17,200
+219% +$2.2M
JAZZ icon
15
Jazz Pharmaceuticals
JAZZ
$15.9B
$3.5M 1.47%
22,411
HZNP
16
DELISTED
Horizon Therapeutics Public Limited Company Ordinary Shares
HZNP
$3.47M 1.46%
43,490
+10,000
+30% +$947K
CTIC
17
DELISTED
CTI BioPharma Corp. (DE) Common Stock
CTIC
$3.38M 1.42%
566,687
+10,000
+2% +$51.2K
INCY icon
18
Incyte
INCY
$25.2B
$3.33M 1.4%
43,820
KW
19
DELISTED
Kennedy-Wilson Holdings
KW
$3.31M 1.39%
175,000
-35,000
-17% -$752K
ABBV icon
20
AbbVie
ABBV
$451B
$3.07M 1.29%
20,037
SRRA
21
DELISTED
Sierra Oncology, Inc. Common Stock
SRRA
$3.07M 1.29%
55,758
GLHAW
22
DELISTED
Glass Houses Acquisition Corp. Warrant
GLHAW
$2.88M 1.21%
250,000
EIGR
23
DELISTED
Eiger BioPharmaceuticals, Inc.
EIGR
$2.58M 1.08%
13,643
+667
+5% +$134K
VXX icon
24
iPath Series B S&P 500 VIX Short-Term Futures ETN
VXX
$133M
$2.31M 0.97%
6,250
-9,375
-60% -$3.7M
JPM icon
25
JPMorgan Chase
JPM
$951B
$2.3M 0.96%
20,385
+165
+0.8% +$20.4K

Similar funds

David M. Knott Jr's Q2 2022 Portfolio in Review

As of Q2 2022, David M. Knott Jr held 208 positions worth $238M, down 24% from $314M the previous quarter. Its ten largest holdings account for 53% of the portfolio.

David M. Knott Jr withdrew a net $35M in Q2 2022, closing 20 positions and reducing 13 holdings. Its most notable exit was Twelve Seas Investment Company II Class A Common Stock, an estimated $4.88M position sold in full.

By sector, the portfolio is most concentrated in Healthcare at 34% of assets, up from 29% a quarter earlier, followed by Materials and Miscellaneous.

Against the trend, David M. Knott Jr opened a new position in The Mosaic Company worth $1.65M.

  • David M. Knott Jr's largest Q2 2022 buy was The Mosaic Company: 35,000 shares worth $1.65M.
  • David M. Knott Jr added most to Franklin BSP Realty Trust in Q2 2022, an estimated $3.73M increase.
  • David M. Knott Jr's biggest Q2 2022 reduction was iPath Series B S&P 500 VIX Short-Term Futures ETN, cutting an estimated $3.7M.
  • David M. Knott Jr fully exited Twelve Seas Investment Company II Class A Common Stock in Q2 2022, selling an estimated $4.88M.
  • David M. Knott Jr's ten largest holdings make up 53% of its $238M portfolio in Q2 2022.
  • David M. Knott Jr opened 68 new positions and closed 20 in Q2 2022.
  • David M. Knott Jr's portfolio value fell 24% quarter-over-quarter to $238M.

Based on David M. Knott Jr's 13F filing for Q2 2022, filed 11 Aug 2022.